Menopause marks the end of a woman’s childbearing years, but it doesn’t mark the end of the need for a particular screening ...

Aotearoa New Zealand has embraced self-tests for cervical screening with a University of Otago–Ōtākou Whakaihu Waka-led study ...

April is Head and Neck Cancer Awareness Month, a critical time to shine a spotlight on a disease that often goes undetected ...

At its meeting on Tuesday, the CDC's Advisory Committee on Immunization Practices (ACIP) considered whether the U.S. should ...

The 9-valent HPV vaccine targets sub-types 6, 11, 16, 18, 31, 33, 45, 52 and 58 among Indian girls and women (aged 9-26 years) and boys (aged 9- 15 years). The vaccine helps protect against cervical ...

over 4,000 American women will die this year of cervical cancer primarily due to inadequate screening. Our goal is to make HPV screening more accessible and discreet for women who may otherwise ...

over 4,000 American women will die this year of cervical cancer primarily due to inadequate screening. Our goal is to make HPV screening more accessible and discreet for women who may otherwise skip ...

Cervical cancer in women has long been the cancer primarily associated with HPV, and that shows in the survey results from OSUCCC. Nearly half of the respondents believe that HPV is more common in ...

“Achieving cervical elimination does not mean ‘fixing’ one thing – it needs several different strategies and evidence-based approaches across HPV vaccination, improving screening uptake ...

Cervical cancer leads to approximately 685 deaths a year in England and most cervical cancer cases (99.8%) are caused by the human papillomavirus (HPV) virus. By increasing equitable uptake of both ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Japan approves Tivdak, the first ADC for cervical cancer, after Phase 3 trial shows a 30% reduction in death risk vs. chemotherapy. The trial of 502 patients showed Tivdak improved median overall ...